Ranking Alexa Global: # 9,740,283
Server:Apache/2.4.33 (Unix)...
X-Powered-By:PHP/7.0.30
The main IP address: 212.48.94.189,Your server United Kingdom,Derby ISP:Webfusion Internet Solutions TLD:com CountryCode:GB
The description :home science about news contact home science about news contact welcome to capella bioscience developing a strong portfolio of mabs in oncology and autoimmune disease. find out more developing through...
This report updates in 05-Feb-2019
Created Date: | 2014-10-13 |
Changed Date: | 2016-09-22 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host capellabioscience.com. Currently, hosted in United Kingdom and its service provider is Webfusion Internet Solutions .
Latitude: | 52.922771453857 |
Longitude: | -1.4766299724579 |
Country: | United Kingdom (GB) |
City: | Derby |
Region: | England |
ISP: | Webfusion Internet Solutions |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.33 (Unix) containing the details of what the browser wants and will accept back from the web server.
Content-Type: | text/html; charset=UTF-8 |
Expires: | Tue, 05 Feb 2019 14:20:53 GMT |
X-Powered-By: | PHP/7.0.30 |
Transfer-Encoding: | chunked |
x-cache-handler: | wp |
Content-Encoding: | gzip |
Server: | Apache/2.4.33 (Unix) |
Last-Modified: | Thu, 13 Dec 2018 04:07:56 GMT |
Cache-Control: | max-age=3600 |
Date: | Tue, 05 Feb 2019 13:20:53 GMT |
X-Hostname: | cweb1-c9203 |
soa: | ns.123-reg.co.uk. hostmaster.capellabioscience.com. 2014101302 14400 0 604800 14400 |
ns: | ns.123-reg.co.uk. ns2.123-reg.co.uk. |
ipv4: | IP:212.48.94.189 ASN:20738 OWNER:AS20738, GB Country:GB |
mx: | MX preference = 20, mail exchanger = cluster3a.eu.messagelabs.com. MX preference = 10, mail exchanger = cluster3.eu.messagelabs.com. |
home science about news contact home science about news contact welcome to capella bioscience developing a strong portfolio of mabs in oncology and autoimmune disease. find out more developing through innovation our strategy is to use novel technologies to develop monoclonal antibodies (mabs) to innovative and therapeutic targets in oncology and autoimmune disease. our in-house mab pipeline maximises our technology's application in the development of novel medicines. see more / 2 / 2 technology our strategy is to use novel technologies to develop monoclonal antibodies (mabs) to innovative and therapeutic targets in oncology and autoimmune disease. our in-house mab pipeline maximises our technology’s application in the development of novel medicines. experience the company has a highly experienced leadership team and board of directors whom have proven track records of successfully developing marketed therapeutic biologics and growing multimillion dollar companies. our mission founded in 2014, capella bioscience raised £1.5m of equity financing from advent life sciences and index ventures. this enables our mission to advance our pipeline of first-in-class mab therapeutics in areas of high unmet medical need. capella bioscience. developing innovative mabs. we are developing a strong portfolio of mabs in oncology and autoimmune disease. find out more about us our strategy is to use innovative technologies to develop novel medicines based on monoclonal antibodies (mabs) to the next generation of important therapeutic targets in oncology and autoimmune disease. find out more useful links about us privacy policy cookie policy terms & conditions london, uk offices capella bioscience 158-160 north gower street london, nw1 2nd email: [email protected]
http://www.capellabioscience.com/privacy-policy/
http://www.capellabioscience.com/terms-conditions/
http://www.capellabioscience.com/about/
http://www.capellabioscience.com/#qode-capella-home-slider
http://www.capellabioscience.com/contact/
http://www.capellabioscience.com/about/
http://www.capellabioscience.com/news/
http://www.capellabioscience.com/science/
http://www.capellabioscience.com/science/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: CAPELLABIOSCIENCE.COM
Registry Domain ID: 1880141718_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2016-09-22T15:16:19Z
Creation Date: 2014-10-13T08:46:50Z
Registry Expiry Date: 2018-10-13T08:46:50Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS.123-REG.CO.UK
Name Server: NS2.123-REG.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-04-11T19:36:46Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR 123-Reg Limited
SERVERS
SERVER com.whois-servers.net
ARGS domain =capellabioscience.com
PORT 43
TYPE domain
DOMAIN
NAME capellabioscience.com
CHANGED 2016-09-22
CREATED 2014-10-13
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
NSERVER
NS.123-REG.CO.UK 212.67.202.2
NS2.123-REG.CO.UK 62.138.132.21
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .